Drug intelligence / Profile preview

AAV9-shCon

Development stage
Preclinical
Modality
Viral-delivered RNAi → In Vivo RNAi → Gene Silencing → Gene Therapies, Gene Editing → Gene Therapies, Gene Addition/Replacement → Gene Therapies
Administration
Intravenous, Intrathecal, Parenteral
01

Overview

AAV9-shCon is a research-grade viral vector used as a negative control in gene silencing experiments, particularly those involving RNA interference (RNAi). It consists of an adeno-associated virus serotype 9 (AAV9) capsid packaging a genetic payload that expresses a non-targeting, or 'scrambled,' short hairpin RNA (shRNA). AAV9 is a widely utilized vector in neuroscience due to its ability to cross the blood-brain barrier and efficiently transduce various CNS cell types, including neurons and astrocytes. In preclinical models of Alzheimer's disease and neurovascular dysfunction, AAV9-shCon serves as a critical baseline to control for the biological effects of viral transduction and shRNA expression, allowing researchers to isolate the specific effects of knocking down a target gene, such as Endoglin (ENG).

Other names
AAV9-scrambled-shRNAAAV-9-scrambled-shRNAAAV 9-scrambled-shRNAAAV9-non-targeting-shRNAAAV-9-non-targeting-shRNAAAV 9-non-targeting-shRNA

Beyond the preview

Go deeper on AAV9-shCon.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on AAV9-shCon.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call